Peru-15 (Choleragarde(®)), a live attenuated oral cholera vaccine, is safe and immunogenic in human immunodeficiency virus (HIV)-seropositive adults in Thailand (Q40661355)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 2015

Language	Label	Description	Also known as
English	Peru-15 (Choleragarde(®)), a live attenuated oral cholera vaccine, is safe and immunogenic in human immunodeficiency virus (HIV)-seropositive adults in Thailand	scientific article published on August 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Peru-15 (Choleragarde(®)), a live attenuated oral cholera vaccine, is safe and immunogenic in human immunodeficiency virus (HIV)-seropositive adults in Thailand (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

0 references

0 references

attenuated vaccine

1 reference

based on heuristic

inferred from title

Anna Lena Lopez

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26241948 AND SRC:MED&resulttype=core&format=json

31 May 2020

author name string

W Ratanasuwan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26241948 AND SRC:MED&resulttype=core&format=json

31 May 2020

Y H Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26241948 AND SRC:MED&resulttype=core&format=json

31 May 2020

B K Sah

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26241948 AND SRC:MED&resulttype=core&format=json

31 May 2020

S Suwanagool

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26241948 AND SRC:MED&resulttype=core&format=json

31 May 2020

D R Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26241948 AND SRC:MED&resulttype=core&format=json

31 May 2020

A Anekthananon

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26241948 AND SRC:MED&resulttype=core&format=json

31 May 2020

W Techasathit

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26241948 AND SRC:MED&resulttype=core&format=json

31 May 2020

S L Grahek

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26241948 AND SRC:MED&resulttype=core&format=json

31 May 2020

J D Clemens

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26241948 AND SRC:MED&resulttype=core&format=json

31 May 2020

T F Wierzba

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26241948 AND SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

0 references

publication date

1 August 2015

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26241948 AND SRC:MED&resulttype=core&format=json

31 May 2020

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26241948 AND SRC:MED&resulttype=core&format=json

31 May 2020

38

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26241948 AND SRC:MED&resulttype=core&format=json

31 May 2020

4820-4826

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26241948 AND SRC:MED&resulttype=core&format=json

31 May 2020

The global burden of cholera.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

HIV seropositivity and cholera in refugee children from Rwanda.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

Review of reported cholera outbreaks worldwide, 1995-2005.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

Is HIV infection associated with an increased risk for cholera? Findings from a case-control study in Mozambique

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

Intestinal antibody responses to oral vaccination in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

Evaluation of Peru-15, a new live oral vaccine for cholera, in volunteers

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

A cholera outbreak of the Vibrio cholerae O1 El Tor variant carrying classical CtxB in northeastern Thailand in 2007.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

Diminished diarrheal response to Vibrio cholerae strains carrying the replicative form of the CTX(Phi) genome instead of CTX(Phi) lysogens in adult rabbits

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

Vaccination and HIV: a review of the literature

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

Increase in plasma viral load after oral cholera immunization of HIV-infected subjects

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

Immunization of the HIV infected traveller

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

Immune response following oral administration of cholera toxin B subunit to HIV-1-infected UK and Kenyan subjects

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2015.07.073

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2015.07.073

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26241948 AND SRC:MED&resulttype=core&format=json

31 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26241948 AND SRC:MED&resulttype=core&format=json

31 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40661355&oldid=1904278244"